Thanks @JB1975. You've more than somewhat diverted my points over to your oft expressed, and possibly correct, potency assays doubts for MSB's product. I don't wish to get involved in matters beyond my scientific understanding. I wasn't writing about that.
If you wish to address my post in reply to Sector please confine it to (a) whether or not there is a placebo arm and (b) would FDA approval (putting aside your doubts for a moment) of remstemcel for aGvHD make recruitment difficult for the CYP trial. If it weren't for Sector tagging me on the placebo matter I wouldn't even be here. I don't post here unless he tags me.
CYP Price at posting:
31.0¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)